UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059737
Receipt number R000068312
Scientific Title A Clinical Study on the Correlation Between Exercise Intensities Corresponding to the Anaerobic Threshold (AT) Measured by the Standard Cardiopulmonary Exercise Testing Using Respiratory Gas Analysis and the Oxygen Saturation Threshold (ST) Measured by the Novel S-Slope Method in Patients with Chronic Kidney Disease
Date of disclosure of the study information 2026/01/01
Last modified on 2026/02/01 18:42:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Clinical Study on the Correlation Between Exercise Intensities Corresponding to the Anaerobic Threshold (AT) Measured by the Standard Cardiopulmonary Exercise Testing Using Respiratory Gas Analysis and the Oxygen Saturation Threshold (ST) Measured by the Novel S-Slope Method in Patients with Chronic Kidney Disease

Acronym

A Clinical Study of the Anaerobic Threshold (AT) and the Oxygen Saturation Threshold (ST) Determined by Cardiopulmonary Exercise Testing in Patients with Chronic Kidney Disease

Scientific Title

A Clinical Study on the Correlation Between Exercise Intensities Corresponding to the Anaerobic Threshold (AT) Measured by the Standard Cardiopulmonary Exercise Testing Using Respiratory Gas Analysis and the Oxygen Saturation Threshold (ST) Measured by the Novel S-Slope Method in Patients with Chronic Kidney Disease

Scientific Title:Acronym

A Clinical Study of the Anaerobic Threshold (AT) and the Oxygen Saturation Threshold (ST) Determined by Cardiopulmonary Exercise Testing in Patients with Chronic Kidney Disease

Region

Japan


Condition

Condition

Chronic Kidney Disease

Classification by specialty

Nephrology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the correlation between exercise intensity at the anaerobic threshold (AT) using the "exhaled gas analysis method," a standard measurement method for cardiopulmonary exercise stress testing, and exercise intensity corresponding to the oxygen saturation threshold (ST) using the "S-Slope method," in patients with chronic kidney disease (CKD), and to examine whether ST can be used as a substitute for AT in CKD patients.

Basic objectives2

Others

Basic objectives -Others

To examine the correlation between exercise intensity corresponding to the indices (AT and ST) obtained using two measurement methods.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Correlation between exercise intensity corresponding to AT defined by heart rate and that corresponding to ST defined by pulse rate (PR)

Key secondary outcomes

Correlation between other exercise intensities corresponding to AT and ST defined as watt and VO2


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients diagnosed with chronic kidney disease (CKD)
2) Patients appropriate for exercise therapy
3) Patients aged between 20 and 80 years
4) Patients who have provided written informed consent

Key exclusion criteria

1) Patients who have intolerance to high-intensity exercise
2) Patients with exercise-induced disorders such as exercise-induced arrhythmia or exercise-induced anaphylaxis, or those with musculoskeletal impairments that limit exercise
3) Patients who wish to become pregnant during the study period, and pregnant or breastfeeding woman
4) Patients who are participating in, or are scheduled to participate in another clinical study
5) Any other patients deemed inappropriate for participation in this study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Masanobu
Middle name
Last name KAWASAKI

Organization

Kohokai Medical Corporation, Sugamo Kidney Clinic

Division name

Chairman / Director

Zip code

170-0002

Address

Sugamo Toho Building 8th Floors, 1-18-8 Sugamo, Toshima-ku, Tokyo, Japan

TEL

03-6902-3880

Email

mk@shioyakai.com


Public contact

Name of contact person

1st name Masanobu
Middle name
Last name KAWASAKI

Organization

Kohokai Medical Corporation, Sugamo Kidney Clinic

Division name

Chairman / Director

Zip code

170-0002

Address

Sugamo Toho Building 8th Floors, 1-18-8 Sugamo, Toshima-ku, Tokyo, Japan

TEL

03-6902-3880

Homepage URL


Email

mk@shioyakai.com


Sponsor or person

Institute

Kohokai Medical Corporation, Sugamo Kidney Clinic

Institute

Department

Personal name



Funding Source

Organization

FANCL CORPORATION

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institute of Science Tokyo, Ethical Review Committee

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, JAPAN

Tel

03-5803-4547

Email

rinri.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人湖歩会 すがも腎クリニック(東京都)
株式会社ファンケル(神奈川県)
東京科学大学(東京都)


Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 11 Month 11 Day

Date of IRB

2026 Year 01 Month 27 Day

Anticipated trial start date

2026 Year 02 Month 01 Day

Last follow-up date

2026 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To examine the correlation between exercise intensity corresponding to the indices (AT and ST) obtained using two measurement methods.


Management information

Registered date

2025 Year 11 Month 11 Day

Last modified on

2026 Year 02 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068312